Risk assessment, symptoms, and signs as predictors of vulvovaginal and cervical infections in an urban US STD clinic: Implications for use of STD algorithms

Sexually Transmitted Infections

Volumn 74, Issue SUPPL. 1, 1998, Pages

  Ryan, Caroline A ^a   Courtois, Barry N ^a   Hawes, Stephen E ^a   Stevens, Claire E ^a   Eschenbach, David A ^b   Holmes, King K ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical infections; Risk assessment; STD clinics; United States; Vulvovaginal infections

Indexed keywords

ADULT; ALGORITHM; ARTICLE; CANDIDA ALBICANS; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEXUALLY TRANSMITTED DISEASE; SYMPTOMATOLOGY; UNITED STATES; UTERINE CERVICITIS; VAGINA DISCHARGE; VULVOVAGINITIS; WORLD HEALTH ORGANIZATION;

ADULT; ALGORITHMS; BACTERIOLOGICAL TECHNIQUES; FEMALE; HUMANS; PROGRAM EVALUATION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASES; URBAN HEALTH; URBAN HEALTH SERVICES; UTERINE CERVICAL DISEASES; VAGINAL DISEASES; VULVAR DISEASES; WASHINGTON;

EID: 0031826792     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Britten TF, DeLisle S, Fine D. STDs and family planning clinics: a regional program for chlamydia that works. Am J Gynecol Health 1992;24-31.
2. Addiss DG, Vaugh ML, Ludka D, et al. Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin. Sex Transm Dis 1993;20:28-35.
3. Vuylsteke B, Laga M, Alary M, et al. Clinical algorithms for the screening of women for gonococcal and chlamydial infection: evaluation of pregnant women and prostitutes in Zaire. Clin Infect Dis 1993;17:82-8.
4. Behets FMT, Williams Y, Brathwaite A, et al. Management of vaginal discharge in women treated at a Jamaican sexually transmitted disease clinic: use of diagnostic algorithms versus laboratory testing. Clin Infect Dis 1995;21:1450-5.
5. World Health Organisation. Global programme on AIDS. Management of sexually transmitted diseases. WHO/GPA/TEM/94.1 Geneva: WHO, 1994.
6. Holmes KK. Lower genital tract infections in women: cystitis, urethritis, vulvovaginitis, and cervicitis. In: Holmes KK, Mardh PA, Sparling PF, Wiesner PJ, Cates W Jr, Lemon SM, Stamm WE, eds. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990:527-46.
7. Eschenbach DA, Hillier S, Critchlow C, et al. Diagnosis and clinical manifestation of bacterial vaginosis. Am J Obstet Gynecol 1988;158:819-28.
8. Wolner-Hanssen P, Krieger JN, Stevens CE, et al. Clinical manifestations of vaginal trichomoniasis. JAMA 1989;261:571-6.
9. Ekhert LO, Hawes SE, DeRouen TA, et al. Clinical manifestations of vulvovaginal candidiasis: clinical manifestations, risk factors, and algorithm for case management. (Submitted.)
10. Diamond LS. The establishment of various trichomonads of animal and man in axenic cultures. J Parasitol 1957;43:488-90.
11. Stamm WE, Tam M, Koester M, et al. Detection of Chlamydia trachomatis inclusions in McCoy cell cultures with fluorescein-conjugated monoclonal antibodies. J Clin Microbiol 1983;17:666-8.
12. Peterson EP, Schmidt OW, Goldstein LC, et al. Typing of clinical HSV isolates using mouse monoclonal antibodies to HSV-1 and HSV-2: comparison with type-specific rabbit antisera and restriction endonuclease analysis of viral DNA. J Clin Microbiol 1983;17:92-6.
13. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22.
14. Costello Daly C, Maggwa N, Mati JK, et al. Risk factors for gonorrhea, syphilis, and trichomonas infections among women attending family planning clinics in Nairobi, Kenya. Genitourin Med 1994;70:155-61.
15. Braddick MR, Ndinya-Achola JO, Mirza NB, et al. Toward developing a diagnostic algorithm for Chlamydia trachomatis and Neisseria gonorrhoeae cervicitis in pregnancy. Genitourin Med 1990;66:62-5.
16. Behets FMT, Desormeaux J, Joseph D, et al. Control of sexually transmitted diseases in Haiti: results and implications of a baseline study among pregnant women living in Cité Soleil shantytowns. J Infect Dis 1995;172:764-71.
17. Eng TR, Butler WT, eds. The hidden epidemic: confronting sexually transmitted diseases. Washington, DC: Institute of Medicine, National Academy Press, 1997.
18. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334:1362-6.
19. Hillier SL, Kiviat NB, Hawes SE, et al. Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol 1996;175:435-41.
20. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med 1995;333:1737-42.
21. Hauth JC, Goldenberg RL, Andrews WW, et al. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732-6.
22. Cohen CR, Duerr A, Pruithithada N, et al. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 1995;9:1093-7.
23. Sewankambo N, Gray RH, Wawer MJ, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997;350:546-50.
24. Taha TE, Kumwenda NI, Liomba GN, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. (in press)
25. Martin HL, Nyange PM, Richardson BA, et al. Association between presence of vaginal lactobacilli and acquisition of HIV and STDs. Vancouver: XI International Conference on AIDS, July 1996:7-12 (abstract).